Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation-Reference-Cited by-同舟云学术

Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation

Published:2016-12 Issue: Volume:173 Page:147-148
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Koga Tomohiro^ORCID,Sato Tomohito,Umeda Masataka,Fukui Shoichi,Horai Yoshiro,Kawashiri Shin-ya,Iwamoto Naoki,Ichinose Kunihiro,Nakamura Hideki,Kawakami Atsushi

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference10 articles.

1. Palmoplantar pustulosis: a clinical and immunohistological study;Eriksson;Br. J. Dermatol.,1998

2. Increased peripheral Th17 in patients with pustulosis palmaris et plantaris;Torii;Arch. Dermatol. Res.,2011

3. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis;Hagforsen;Br. J. Dermatol.,2010

4. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum;Murakami;Exp. Dermatol.,2011

5. Palmoplantar pustular psoriasis induced by adalimumab: a case report and literature review;Ibis;Immunotherapy,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature;International Immunopharmacology;2024-09

2. Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial;American Journal of Clinical Dermatology;2024-07-02

3. Palmoplantar pustulosis with psoriatic arthritis ineffective to interleukin-17 inhibitors: two patients successfully treated with upadacitinib;Journal of Dermatological Treatment;2023-11-15

4. Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors;Frontiers in Immunology;2023-11-03

5. Therapieansprechen der palmoplantaren Pustulose auf Upadacitinib: eine Fallserie von fünf Patienten;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-11